Catalysts for $AXSM
8 tracked
Nov 2, 2026
earnings
Axsome Therapeutics, Inc. earnings
Axsome Therapeutics, Inc.
→
Aug 10, 2026
earnings
Axsome Therapeutics, Inc. earnings
Axsome Therapeutics, Inc.
→
Aug 3, 2026
earnings
Axsome Therapeutics, Inc. earnings
Axsome Therapeutics, Inc.
→
May 4, 2026
earnings
Axsome Therapeutics, Inc. earnings
Axsome Therapeutics, Inc.
→
Apr 30, 2026
pdufa
Axsome Therapeutics Inc — (bupropion hydrochloride + dextromethorphan) ER (PDUFA)
(bupropion hydrochloride + dextromethorphan) ER
→
Nov 5, 2025
approval
AUVELITY (BUPROPION HYDROCHLORIDE) — FDA approval
(bupropion hydrochloride + dextromethorphan) ER
→
May 7, 2024
approval
AUVELITY (BUPROPION HYDROCHLORIDE) — FDA approval
(bupropion hydrochloride + dextromethorphan) ER
→
Aug 18, 2022
approval
AUVELITY (BUPROPION HYDROCHLORIDE) — FDA approval
(bupropion hydrochloride + dextromethorphan) ER
→